Multicenter Evaluation of the Chinese Disseminated Intravascular Coagulation Scoring System

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-DPD-15006563

Enrollment

Unknown

Registered

2015-06-12

Start date

2015-06-15

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disseminated intravascular coagulation

Interventions

Gold Standard:

Index test:

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. DIC related underlying disease; 2. Any one in the following: PT>3s, FDP>10ug/ml, D-Dimer> 5FEU, Fbg<1.0g/L, PLT<120G/L.

Exclusion criteria

Exclusion criteria: 1. Severe hepatitis (Chid-phugh grade C); 2. Thrombotic thrombocytopenic purpura; 3. Heparin induced thrombocytopenic purpura; 4. Antiphospholipid syndrome.

Design outcomes

Primary

Measure	Time frame
Prothrombin time, PT;Activated partial thromboplastin time, APTT;Fibrin(-ogen) degradation products, FDPs;D-dimer;Fibrinogen;Platelet;	—

Secondary

Measure	Time frame
Fibrin monomers, FM;Soluble fibrin, SF;High-mobility group protein-1, HMGB-1;Antithrombin, AT?;Plasminogen activator inhibitor-1, PAI-1;Thrombin-antithrombin, TAT;	—

Countries

China

Contacts

Public ContactYu Hu

dr_huyu@126.com+86 13986183871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026